Cite
Mai E, Chan J, Goon L, et al. Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development. J Transl Med. 2021;19(1):517doi: 10.1186/s12967-021-03189-3.
Mai, E., Chan, J., Goon, L., Ego, B. K., Bevers, J., Wong, T., Wong, M., Corpuz, R., Xi, H., Wu, J., Schneider, K., Seshasayee, D., Grimbaldeston, M., Nakamura, G., Indjeian, V. B., van Lookeren Campagne, M., Loyet, K. M., & Comps-Agrar, L. (2021). Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development. Journal of translational medicine, 19(1), 517. https://doi.org/10.1186/s12967-021-03189-3
Mai, Elaine, et al. "Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development." Journal of translational medicine vol. 19,1 (2021): 517. doi: https://doi.org/10.1186/s12967-021-03189-3
Mai E, Chan J, Goon L, Ego BK, Bevers J, Wong T, Wong M, Corpuz R, Xi H, Wu J, Schneider K, Seshasayee D, Grimbaldeston M, Nakamura G, Indjeian VB, van Lookeren Campagne M, Loyet KM, Comps-Agrar L. Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development. J Transl Med. 2021 Dec 20;19(1):517. doi: 10.1186/s12967-021-03189-3. PMID: 34930320; PMCID: PMC8686655.
Copy
Download .nbib